Mental Health Conditions Glossary: Complete Psychiatric Health Guide

Mental health conditions affect the mind, emotions, behavior, and overall psychological functioning. These disorders are remarkably common, with estimates suggesting that one in four people globally will experience a mental health condition at some point in their lives. In Dubai and the United Arab Emirates, rapid modernization, diverse populations, and the unique challenges of expatriate life have contributed to growing recognition of mental health needs and increasing demand for psychiatric services.

Mental health encompasses emotional, psychological, and social wellbeing. It affects how we think, feel, and act, determining how we handle stress, relate to others, and make choices. Mental illness refers to diagnosable conditions that significantly interfere with thinking, emotional regulation, or behavior, causing distress and impaired functioning.

The brain, though only 2 percent of body weight, consumes 20 percent of the body’s energy. It consists of approximately 86 billion neurons communicating through electrical and chemical signals. Neurotransmitters including serotonin, dopamine, norepinephrine, GABA, and glutamate play key roles in mood, anxiety, and psychosis. Modern psychiatry recognizes that mental illness results from complex interactions between genetic vulnerability, neurobiological factors, and environmental stressors.

Depression

Definition and Overview

Major depressive disorder (MDD), commonly called depression, is a mood disorder characterized by persistent low mood, loss of interest or pleasure, and a range of cognitive and physical symptoms that cause significant distress or impairment. Depression is one of the most common mental health conditions, affecting approximately 280 million people worldwide. It is a leading cause of disability and a major contributor to suicide.

The pathophysiology of depression involves multiple factors. Genetic vulnerability accounts for approximately 40 percent of risk. Neurobiological factors include dysregulation of monoamine neurotransmitters (serotonin, norepinephrine, dopamine), HPA axis hyperactivity, inflammation, and neuroplasticity changes. Environmental factors including stress, trauma, and adverse life events trigger episodes in vulnerable individuals.

Depression can occur at any age, with typical onset in late teens to mid-20s. Risk factors include female sex, family history, prior depression episodes, chronic medical illness, substance use, and certain medications. Postpartum depression and seasonal affective disorder (SAD) are depression subtypes with specific presentations.

Symptoms and Diagnosis

The diagnostic criteria for major depressive episode require five or more of the following symptoms during the same 2-week period, with at least one being either depressed mood or loss of interest: depressed mood most of the day, markedly diminished interest or pleasure, significant weight loss or gain or appetite change, insomnia or hypersomnia, psychomotor agitation or retardation, fatigue, feelings of worthlessness or guilt, diminished ability to think or concentrate, and recurrent thoughts of death or suicide.

Symptoms must cause significant distress or impairment and cannot be attributable to substances or another medical condition. They represent a change from previous functioning.

Physical symptoms are common and may include pain (headaches, back pain, digestive symptoms), fatigue, and changes in appetite and sleep. Cognitive symptoms include difficulty concentrating, making decisions, and negative thinking patterns.

Treatment and Management

Treatment for depression follows a stepped care approach. For mild depression, watchful waiting and psychosocial interventions (counseling, self-help resources) may be appropriate. For moderate to severe depression, combination of antidepressant medication and psychotherapy is most effective.

Antidepressant medications include selective serotonin reuptake inhibitors (SSRIs: sertraline, escitalopram, fluoxetine, paroxetine, citalopram), serotonin-norepinephrine reuptake inhibitors (SNRIs: venlafaxine, duloxetine), and others (bupropion, mirtazapine, trazodone). Response typically occurs after 4-6 weeks of adequate dosing. Side effects vary between agents.

Psychotherapy is as effective as medication for mild to moderate depression and may be preferable for some patients. Cognitive behavioral therapy (CBT) addresses negative thought patterns and behaviors. Interpersonal therapy (IPT) focuses on interpersonal relationships. Other effective therapies include behavioral activation, psychodynamic therapy, and mindfulness-based cognitive therapy.

For treatment-resistant depression (failure of two adequate trials), options include switching medications, augmentation (adding another agent like aripiprazole or lithium), or brain stimulation therapies. Electroconvulsive therapy (ECT) is highly effective for severe, psychotic, or treatment-resistant depression. Transcranial magnetic stimulation (TMS) is approved for treatment-resistant depression.

Lifestyle interventions complement treatment: regular exercise, adequate sleep, balanced diet, social engagement, stress management, and limiting alcohol.

Anxiety Disorders

Definition and Overview

Anxiety disorders are a group of mental health conditions characterized by excessive fear and anxiety that cause significant distress and impairment. Unlike normal anxiety, these conditions involve disproportionate or persistent anxiety that is difficult to control and interferes with daily functioning. Anxiety disorders include generalized anxiety disorder, panic disorder, social anxiety disorder, specific phobias, and others. Collectively, they affect approximately 301 million people worldwide.

Fear is the emotional response to immediate, perceived threat, while anxiety involves anticipation of future threat. Both involve physiological arousal (racing heart, sweating, trembling), cognitive components (worry, catastrophic thinking), and behavioral components (avoidance). The fight-or-flight response, while adaptive for real danger, becomes maladaptive in anxiety disorders.

The pathophysiology involves multiple systems. Genetic factors account for 30-40 percent of risk. Neurobiological factors include amygdala hyperreactivity, prefrontal cortex dysfunction, and neurotransmitter dysregulation (GABA, serotonin, norepinephrine). Environmental factors including childhood adversity and stress contribute to risk.

Generalized Anxiety Disorder

Generalized anxiety disorder (GAD) involves excessive, uncontrollable worry about multiple domains (work, health, family, finances) occurring more days than not for at least 6 months. Physical symptoms include restlessness, fatigue, muscle tension, and sleep disturbance. The worry is difficult to control and causes significant distress or impairment.

GAD often develops gradually and is more common in women. It frequently co-occurs with depression, other anxiety disorders, and substance use. Chronic worry can lead to significant functional impairment and reduced quality of life.

Panic Disorder

Panic disorder is characterized by recurrent, unexpected panic attacks (sudden surge of intense fear with physical symptoms) followed by persistent concern about additional attacks or maladaptive behavior change to avoid attacks. Panic attacks reach peak within 10 minutes and include symptoms like palpitations, sweating, trembling, shortness of breath, feelings of choking, chest pain, nausea, dizziness, chills or heat sensations, paresthesias, derealization, fear of losing control, and fear of dying.

Not all panic attacks indicate panic disorder; they must be recurrent, unexpected, and cause behavioral change. Agoraphobia (fear of situations where escape might be difficult) commonly develops.

Social Anxiety Disorder

Social anxiety disorder (social phobia) involves marked fear or anxiety about social situations where the individual is exposed to possible scrutiny by others. Fear of humiliation, rejection, or offending others leads to avoidance of social situations. Performance anxiety is a common subtype.

Specific Phobias

Specific phobias involve marked fear or anxiety about a specific object or situation (animals, heights, blood-injury-injection, natural environment, situational). The phobic stimulus almost always provokes immediate fear or anxiety and is actively avoided or endured with intense fear.

Treatment for Anxiety Disorders

Treatment for anxiety disorders involves psychotherapy, medication, or combination. Cognitive behavioral therapy is first-line, addressing maladaptive thoughts and behaviors through exposure, cognitive restructuring, and relaxation training. Exposure therapy is particularly effective for phobias and social anxiety.

Medications for anxiety disorders include SSRIs and SNRIs (first-line), benzodiazepines (short-term use only due to dependence risk), and buspirone (for GAD). Beta-blockers (propranolol) are useful for performance anxiety.

Bipolar Disorder

Definition and Overview

Bipolar disorder, formerly called manic-depressive illness, is a mood disorder characterized by episodes of mania or hypomania alternating with episodes of depression. It affects approximately 45 million people worldwide and typically emerges in late adolescence or early adulthood. Bipolar disorder causes significant functional impairment and carries high risk of suicide.

The pathophysiology involves complex interactions between genetic vulnerability and environmental triggers. Multiple genes contribute small effects, with heritability estimated at 60-85 percent. Neurobiological factors include dysregulation of neurotransmitter systems, circadian rhythm disturbances, and neuroendocrine abnormalities.

Bipolar disorder is classified into several types. Bipolar I disorder requires at least one manic episode (which may be preceded or followed by hypomanic or major depressive episodes). Bipolar II disorder requires at least one hypomanic episode and one major depressive episode (no manic episodes). Cyclothymic disorder involves numerous periods of hypomanic and depressive symptoms that do not meet criteria for full episodes.

Symptoms and Diagnosis

Manic episodes are characterized by abnormally elevated, expansive, or irritable mood lasting at least one week (or requiring hospitalization) with three or more of the following: inflated self-esteem or grandiosity, decreased need for sleep, more talkative, flight of ideas, distractibility, increased goal-directed activity or psychomotor agitation, and excessive involvement in risky activities.

Hypomanic episodes have the same symptoms but shorter duration (at least 4 days) and no marked impairment or hospitalization. Depressive episodes meet criteria for major depression.

Mixed features (simultaneous manic and depressive symptoms) are common and associated with higher risk. Rapid cycling (four or more episodes in one year) occurs in some patients. Psychotic features (delusions, hallucinations) may occur during severe mania or depression.

Treatment and Management

Mood stabilizers are the foundation of bipolar disorder treatment. Lithium is highly effective for mania, depression prevention, and suicide reduction. Valproate and carbamazepine are alternatives. Lamotrigine is particularly effective for depression prevention.

Atypical antipsychotics (quetiapine, olanzapine, risperidone, aripiprazole, lurasidone) are used for acute mania, depression, and maintenance treatment. Many are approved for bipolar depression.

Acute treatment of mania may require hospitalization, antipsychotics, mood stabilizers, and sometimes benzodiazepines. Acute depression is treated with mood stabilizers, certain antipsychotics (quetiapine, lurasidone), or antidepressant cautiously added with mood stabilizer.

Psychotherapy including psychoeducation, cognitive therapy, family-focused therapy, and interpersonal and social rhythm therapy improves outcomes. Lifestyle regularity (sleep, activity, social rhythms) is important for stability.

Schizophrenia

Definition and Overview

Schizophrenia is a chronic severe mental disorder affecting how a person thinks, feels, and behaves. It is characterized by positive symptoms (hallucinations, delusions, disorganized thinking), negative symptoms (social withdrawal, flat affect, avolition), and cognitive deficits. Schizophrenia affects approximately 24 million people worldwide and typically begins in late adolescence or early adulthood.

The pathophysiology involves multiple genetic and environmental factors. Genetic risk involves many genes of small effect plus rare variants of larger effect. Neurodevelopmental factors are important, with evidence of brain abnormalities preceding symptoms. Neurotransmitter dysregulation includes dopamine (positive symptoms), glutamate, and GABA hypotheses.

Symptoms and Diagnosis

Schizophrenia requires two or more symptoms (one must be delusions, hallucinations, or disorganized speech) present for at least six months, with at least one month of active-phase symptoms. Social or occupational dysfunction is required.

Positive symptoms include hallucinations (most commonly auditory), delusions (often paranoid), disorganized speech, and disorganized or catatonic behavior. Negative symptoms include flat affect, alogia (reduced speech), avolition (reduced motivation), anhedonia, and social withdrawal. Cognitive symptoms include attention, memory, and executive function deficits.

Treatment and Management

Antipsychotic medications are essential for managing schizophrenia. First-generation (typical) antipsychotics (haloperidol, chlorpromazine) primarily block dopamine D2 receptors. Second-generation (atypical) antipsychotics (risperidone, olanzapine, quetiapine, aripiprazole, clozapine) block both dopamine and serotonin receptors and have fewer extrapyramidal side effects.

Clozapine is reserved for treatment-resistant schizophrenia (failure to respond to two adequate trials of other antipsychotics) due to risk of agranulocytosis and other side effects. It is the most effective antipsychotic.

Psychosocial treatments are essential for recovery. Assertive community treatment (ACT) provides intensive community-based care. Supported employment helps with work. Cognitive behavioral therapy for psychosis (CBTp) addresses symptoms and coping. Family education and support improve outcomes.

Integrated treatment for co-occurring substance use disorders is important. Early intervention services improve long-term outcomes.

Post-Traumatic Stress Disorder

Definition and Overview

Post-traumatic stress disorder (PTSD) develops in some people following exposure to actual or threatened death, serious injury, or sexual violence. It is characterized by intrusion symptoms, avoidance, negative alterations in cognition and mood, and hyperarousal. PTSD affects approximately 3.9 percent of the global population, with higher rates in conflict zones and among survivors of violence.

The pathophysiology involves normal fear conditioning responses that become maladaptive. The amygdala is hyperresponsive to trauma cues, while the prefrontal cortex fails to adequately regulate fear responses. Neuroendocrine abnormalities include HPA axis dysregulation.

Symptoms and Diagnosis

Intrusion symptoms include recurrent, involuntary memories, dreams, dissociative reactions, and intense distress at exposure to trauma cues. Avoidance includes efforts to avoid distressing memories, thoughts, or external reminders. Negative alterations include inability to remember important aspects of the trauma, persistent negative beliefs about self or world, persistent negative emotional state, diminished interest, detachment, and persistent inability to experience positive emotions. Hyperarousal includes irritability, recklessness, hypervigilance, exaggerated startle response, and sleep disturbance.

Treatment and Management

Trauma-focused psychotherapies are first-line treatments. Prolonged exposure therapy involves repeated exposure to trauma memories and situations. Cognitive processing therapy (CPT) addresses maladaptive cognitions about the trauma. Eye movement desensitization and reprocessing (EMDR) combines exposure with bilateral stimulation.

Medications can be helpful, particularly SSRIs (sertraline, paroxetine) which are FDA-approved for PTSD. Prazosin may help with nightmares. Treatment should address comorbidities including depression, substance use, and pain.

Obsessive-Compulsive Disorder

Definition and Overview

Obsessive-compulsive disorder (OCD) is characterized by obsessions (recurrent, persistent thoughts, urges, or images causing distress) and compulsions (repetitive behaviors or mental acts performed to reduce distress or prevent a feared event). OCD affects approximately 2 percent of the population worldwide, causing significant distress and functional impairment.

The pathophysiology involves cortico-striato-thalamo-cortical (CSTC) circuit dysfunction. Genetic factors are substantial. Autoimmune mechanisms are implicated in some cases (PANDAS, PANS).

Treatment and Management

Exposure and response prevention (ERP), a form of CBT, is first-line treatment. It involves gradual exposure to feared stimuli while preventing compulsions. ERP is as effective as medication and has longer-lasting effects.

SSRIs are first-line medication treatment, typically at higher doses than for depression. Clomipramine, a tricyclic antidepressant with potent serotonin reuptake inhibition, is also effective. For treatment-resistant OCD, augmentation strategies or clozapine may be considered.

ADHD

Definition and Overview

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning or development. ADHD affects approximately 5 percent of children and 2.5 percent of adults worldwide. It often persists into adulthood.

The pathophysiology involves dopamine and norepinephrine dysregulation in prefrontal-striatal circuits. Genetic factors are substantial (heritability approximately 75 percent). Neuroimaging shows differences in brain structure and function.

Treatment and Management

Stimulant medications (methylphenidate, amphetamines) are first-line treatment for ADHD. They are highly effective but have abuse potential and side effects. Non-stimulant medications (atomoxetine, guanfacine, clonidine) are alternatives.

Behavioral interventions, parent training, and educational accommodations are important, particularly for children. Cognitive training and organizational interventions may help.

Eating Disorders

Overview

Eating disorders are characterized by disturbances in eating behavior and body image. Anorexia nervosa involves restriction of energy intake leading to low body weight, intense fear of gaining weight, and body image disturbance. Bulimia nervosa involves recurrent binge eating followed by compensatory behaviors (purging, fasting, excessive exercise). Binge eating disorder involves recurrent binge eating without purging.

Eating disorders have high mortality rates and significant medical complications. Treatment involves multidisciplinary care including psychotherapy, nutritional rehabilitation, and medical monitoring.

Frequently Asked Questions

Depression Questions

Is depression just sadness? No, depression is a medical illness with physical and cognitive symptoms beyond sadness. It causes significant impairment and cannot be overcome by “trying harder.”

Can depression be cured? Most people with depression improve with treatment. Some achieve full recovery; others manage recurring episodes. Long-term treatment may be needed for recurrent depression.

Are antidepressants addictive? No, antidepressants are not addictive. They do not produce euphoria or craving. Discontinuation symptoms can occur if stopped abruptly.

Does exercise help depression? Yes, regular exercise has antidepressant effects comparable to medication for mild to moderate depression. It is recommended as part of treatment.

Anxiety Questions

Is anxiety a mental illness? Normal anxiety is adaptive. When anxiety is excessive, persistent, and impairing, it becomes a disorder requiring treatment.

Can anxiety be cured? Anxiety disorders can be effectively managed. Complete cure is possible, particularly with effective therapy. Many people achieve long-term remission.

Are benzodiazepines safe long-term? Benzodiazepines have dependence and tolerance risks. They are generally recommended for short-term use only. Longer-term use requires careful monitoring.

Is CBT effective for anxiety? Yes, CBT is highly effective for most anxiety disorders. It is often first-line treatment, either alone or with medication.

Bipolar Disorder Questions

Is bipolar disorder the same as mood swings? Bipolar disorder involves distinct episodes of mania/hypomania and depression, not normal mood swings. The episodes are severe and persistent.

Do people with bipolar disorder need medication forever? Most people with bipolar disorder require long-term medication to prevent episodes. Some may be able to reduce medication under close supervision after periods of stability.

Can lifestyle affect bipolar disorder? Yes, maintaining regular sleep patterns, limiting alcohol, managing stress, and adhering to treatment are important for stability.

Schizophrenia Questions

Is schizophrenia multiple personality? No, schizophrenia is completely different from dissociative identity disorder. It involves psychosis, not multiple personalities.

Can people with schizophrenia recover? Recovery is possible. With comprehensive treatment, many people achieve significant improvement and functional recovery.

Is schizophrenia genetic? Genetics play a significant role, but environment also contributes. Having a relative with schizophrenia increases risk but does not guarantee developing the illness.

PTSD Questions

Who develops PTSD? Anyone exposed to trauma can develop PTSD, though most do not. Risk factors include trauma severity, lack of social support, prior trauma, and genetic vulnerability.

Is PTSD permanent? PTSD can be treated effectively. Many people recover with appropriate treatment, though some have chronic symptoms.

How is PTSD treated? Trauma-focused therapies (prolonged exposure, CPT, EMDR) are first-line. Medications (SSRIs) can help. Treatment should address comorbidities.

General Questions

Do mental health conditions affect physical health? Yes, mental health conditions are associated with increased physical health problems and reduced life expectancy. They also affect treatment outcomes for physical conditions.

Is mental illness a sign of weakness? No, mental illness is a medical condition with biological bases. Seeking help is a sign of strength.

Can lifestyle prevent mental illness? Lifestyle factors (exercise, sleep, diet, social connection, stress management) support mental health and may reduce risk, but cannot prevent all mental illness.

Should I seek professional help? If symptoms persist for more than two weeks and interfere with daily life, professional help is recommended. Early intervention improves outcomes.

Key Takeaways

Mental health conditions affect hundreds of millions of people worldwide, causing significant suffering and disability. Despite their prevalence, stigma and lack of access to care remain barriers to treatment.

Depression, characterized by persistent low mood and anhedonia, is the leading cause of disability globally. Effective treatments including antidepressant medication and psychotherapy help most people improve.

Anxiety disorders, characterized by excessive fear and worry, encompass multiple conditions with different presentations. Treatment options are highly effective, particularly cognitive behavioral approaches.

Bipolar disorder involves alternating episodes of mania and depression. Mood stabilizers and comprehensive treatment prevent episodes and support recovery.

Schizophrenia, a severe mental illness involving psychosis, requires ongoing treatment with antipsychotics and psychosocial support. Recovery is possible with comprehensive care.

PTSD develops following trauma exposure and involves characteristic symptoms. Trauma-focused therapies are highly effective.

OCD involves intrusive thoughts and compulsive behaviors. Exposure and response prevention is the gold standard treatment.

ADHD affects both children and adults, impacting attention, impulse control, and functioning. Medication and behavioral interventions are effective.

For Dubai residents, mental health services are increasingly available, though stigma may still prevent help-seeking. Access to psychiatrists, psychologists, and counselors supports recovery.

Natural support strategies including exercise, social connection, stress management, and adequate sleep complement professional treatment. Traditional approaches including Ayurveda provide additional perspectives on mental wellness.

Section Separator

Related Services

At Healer’s Clinic Dubai, we offer comprehensive mental health support through our integrated services:

• Consultation and Diagnosis: Our experienced psychiatrists provide thorough psychiatric assessments and personalized treatment plans for all mental health conditions.

• Homeopathic Condition Support: Our homeopathic practitioners offer individualized remedies to support mental wellness alongside conventional treatment.

• Ayurvedic Mental Health Care: Traditional Ayurvedic approaches including specialized diet plans (Sattva-increasing foods), herbal formulations (Ashwagandha, Brahmi), yoga, and meditation support mental health from an ancient wellness perspective.

• Mental Wellness Support: Our team provides comprehensive approaches for mental wellbeing, including counseling, lifestyle guidance, and complementary therapies.

Section Separator

Medical Disclaimer: This glossary is provided for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in this material. If you think you may have a medical emergency, call your doctor or emergency services immediately.